Skip to main content

Table 1 The baseline clinical, echocardiographic, and cardiovascular magnetic resonance findings according to the disease

From: Effects of left atrial function on pulmonary arterial pressure in acute myocardial infarction, hypertrophic and dilated cardiomyopathy

Variables

HCM (n = 133)

AMI (n = 123)

DCM (n = 114)

p value

Age (years)

58.5 ± 13.1

55.7 ± 12.2

54.3 ± 15.3*

0.04

Male [n (%)]

97 (73)

111 (90)*

86 (75)

0.001

Body surface area (m2)

1.8 ± 0.2

1.8 ± 0.2

1.8 ± 0.3

0.17

Systolic BP (mmHg)

118 (107, 135)

114 (103, 129)

118 (103, 132)

0.10

Diastolic BP (mmHg)

72 (62, 80)

71 (65, 79)

78 (67, 89)*

0.001

NYHA class

1.42 ± 0.59

1.62 ± 0.61*

2.42 ± 0.65*

< 0.001

Diabetes [n (%)]

25 (19)

27 (22)

20 (18)

0.67

Hypertension [n (%)]

71 (53)

58 (47)

48 (42)

0.21

ACEi/ARB [n (%)]

69 (52)

101 (82)*

96 (84)*

< 0.001

Beta-blocker [n (%)]

92 (69)

104 (85)*

93 (82)

0.01

Diuretics [n (%)]

28 (21)

10 (8)*

81 (71)*

< 0.001

1Atrial fibrillation [n (%)]

14 (11)

3 (2)*

25 (22)*

< 0.001

2NT-proBNP (pg/mL)

711.9 ± 1111.9

 

4845.1 ± 7338..4*

0.004

2BNP (pg/mL)

 

141.3 ± 255.2

1389.5 ± 1233.3

< 0.001

eGFR (mL/m2/1.73 m2)

82.4 ± 13.5

93.0 ± 23.6*

83.5 ± 18.3

< 0.001

Echocardiography

 Relative wall thickness

0.48 (0.42, 0.55)

0.42 (0.38, 0.48)*

0.31 (0.27, 0.36)*

< 0.001

 e′ (cm/s)

5 (4, 6)

6 (5, 7)*

5 (4, 7)

< 0.001

 a′ (cm/s)

8 (7, 9)

9 (7, 10)*

5 (3, 7)*

< 0.001

 s′ (cm/s)

7 (6, 8)

7 (6, 8)

4 (3, 5)*

< 0.001

 E/e′

13.6 (10.6, 18.5)

10.6 (8.8, 13.4)*

16.0 (11.9, 22.3)

< 0.001

 PASP (mmHg)

26.7 (23.4, 31.0)

23.8 (19.4, 28.1)*

38.1 (24.2, 46.8)*

< 0.001

 LAVI (mL/m2)

33.7 (27.7, 46.4)

21.7 (17.4, 26.6)*

49.5 (36.2, 63.9)*

< 0.001

 LVMI (g/m2)

119.8 (101.6, 143.0)

93.14 (77.9, 106.2)*

129.0 (104.8, 149.1)

< 0.001

 LV ejection fraction (%)

70 (66, 73)

48 (42, 55)*

22 (17, 32)*

< 0.001

CMR

 LV-EDVI (mL/m2)

75.62 (65.7, 84.5)

80.62 (71.8, 88.0)

138.69 (111.2, 162.3)*

< 0.001

 LA-GLS (%)

18.8 (13.5, 23.9)

20.7 (16.4, 27.2)

8.4 (4.8, 12.7)*

< 0.001

 LAVImax (mL/m2)

64.0 (50.8, 81.4)

47.9 (39.9, 61.2)*

66.0 (49.6, 81.8)

< 0.001

 LAVImin (mL/m2)

34.9 (23.5, 48.4)

23.47 (17.58, 30.24)*

49.35 (31.59, 66.94)*

< 0.001

 LA preA volume index (mL/m2)

49.17 (33.91, 60.22)

36.4 (28.9, 44.3)*

52.4 (37.0, 68.5)

< 0.001

 LA total emptying fraction (%)

44.7 (35.1, 52.1)

51.2 (44.7, 59.1)*

25.9 (20.2, 38.0)*

< 0.001

 LA reservoir fraction (%)

80.7 (54.0, 108.7)

105.1 (80.8, 144.7)*

35.0 (25.3, 61.3)*

< 0.001

 LA conduit fraction (%)

27.0 (17.4, 36.9)

35.7 (21.6, 45.1)*

16.4 (9.4, 27.2)*

< 0.001

 LA active emptying fraction (%)

30.2 (23.8, 35.3)

35.3 (29.7, 41.8)*

17.9 (9.0, 31.6)*

< 0.001

 E/e′/LA-GLS (%)

0.7 (0.5, 1.3)

0.5 (0.4, 0.8)*

1.9 (1.1, 4.3)*

< 0.001

 ECVavg (%)

31.9 (28.8, 35.3)

37.2 (33.9, 42.2)*

33.6 (30.2, 35.9)

< 0.001

  1. 1At the time of the echocardiography or CMR; 2NT-proBNPs were done in 29 HCM and 40 DCM patients, BNP in 39 AMI and 52 DCM patients;.a′, late diastolic mitral annular velocity; ACEi, angiotensin-converting enzyme inhibitor; AMI, acute myocardial infarction; ARB, angiotensin receptor blocker; BNP, B-type natriuretic peptide; CAD, coronary artery disease; CMR, cardiovascular magnetic resonance; DCM, dilated cardiomyopathy; e′, early diastolic mitral annular velocity; ECV, extracellular volume fraction; EDVI, end-diastolic volume index; eGFR, estimated glomerular filtration rate; GLS, global longitudinal strain; HCM, hypertrophic cardiomyopathy; LA, left atrial; LAVImax, maximal LA volume index; LAVImin, minimal LA volume index; LGE, late gadolinium enhancement; LV, left ventricular; NT-proBNP, N-terminal pro-BNP; NYHA, New-York Heart Association; PASP, pulmonary arterial systolic pressure; s′, systolic mitral annular velocity
  2. *p < 0.0167 compared to HCM, p < 0.0167 compared to DCM